1. Home
  2. BIVI vs WTO Comparison

BIVI vs WTO Comparison

Compare BIVI & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • WTO
  • Stock Information
  • Founded
  • BIVI 2013
  • WTO 2008
  • Country
  • BIVI United States
  • WTO China
  • Employees
  • BIVI N/A
  • WTO N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • WTO Consumer Electronics/Appliances
  • Sector
  • BIVI Health Care
  • WTO Technology
  • Exchange
  • BIVI Nasdaq
  • WTO Nasdaq
  • Market Cap
  • BIVI 11.9M
  • WTO 12.6M
  • IPO Year
  • BIVI N/A
  • WTO 2021
  • Fundamental
  • Price
  • BIVI $1.87
  • WTO $1.34
  • Analyst Decision
  • BIVI
  • WTO
  • Analyst Count
  • BIVI 0
  • WTO 0
  • Target Price
  • BIVI N/A
  • WTO N/A
  • AVG Volume (30 Days)
  • BIVI 316.9K
  • WTO 519.6K
  • Earning Date
  • BIVI 11-12-2025
  • WTO 09-23-2025
  • Dividend Yield
  • BIVI N/A
  • WTO N/A
  • EPS Growth
  • BIVI N/A
  • WTO N/A
  • EPS
  • BIVI N/A
  • WTO N/A
  • Revenue
  • BIVI N/A
  • WTO $34,589,265.00
  • Revenue This Year
  • BIVI N/A
  • WTO N/A
  • Revenue Next Year
  • BIVI N/A
  • WTO N/A
  • P/E Ratio
  • BIVI N/A
  • WTO N/A
  • Revenue Growth
  • BIVI N/A
  • WTO 54.01
  • 52 Week Low
  • BIVI $1.42
  • WTO $0.75
  • 52 Week High
  • BIVI $75.00
  • WTO $8.56
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 33.55
  • WTO 68.75
  • Support Level
  • BIVI $1.54
  • WTO $1.03
  • Resistance Level
  • BIVI $1.68
  • WTO $1.40
  • Average True Range (ATR)
  • BIVI 0.14
  • WTO 0.12
  • MACD
  • BIVI 0.26
  • WTO 0.05
  • Stochastic Oscillator
  • BIVI 73.77
  • WTO 70.76

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks: